Asian Paints:2,640.00+14.70 (+0.56%)
Cipla:1,432.20-5.75 (-0.40%)
Eicher Motors:8,010.00-32.17 (-0.40%)
Nestle India:1,477.10+19.10 (+1.31%)
Grasim Inds:3,308.00+7.92 (+0.24%)
Hindalco Inds.:1,034.00+4.12 (+0.40%)
Hind. Unilever:2,015.00-12.98 (-0.64%)
ITC:269.40-2.25 (-0.83%)
Trent:2,924.00-46.04 (-1.55%)
Larsen & Toubro:4,093.00+11.84 (+0.29%)
M & M:3,412.20-12.67 (-0.37%)
Reliance Industries:1,316.00+2.76 (+0.21%)
Tata Consumer:1,049.00-7.29 (-0.69%)
Tata Motors PVeh:317.90-2.34 (-0.73%)
Tata Steel:183.00-0.50 (-0.27%)
Wipro:180.79-0.22 (-0.12%)
Apollo Hospitals:8,693.00-41.93 (-0.48%)
Dr Reddy's Labs:1,174.70-5.31 (-0.45%)
Titan Company:5,086.10+18.24 (+0.36%)
SBI:1,048.70+0.73 (+0.07%)
Shriram Finance:1,130.00+1.81 (+0.16%)
Bharat Electron:414.00+4.59 (+1.12%)
Kotak Mah. Bank:402.80+5.44 (+1.37%)
Infosys:1,121.00-9.04 (-0.80%)
Bajaj Finance:1,095.00+0.00 (+0.00%)
Adani Enterp.:2,997.00+2.10 (+0.07%)
Sun Pharma.Inds.:1,902.40-1.52 (-0.08%)
JSW Steel:1,293.70-5.98 (-0.46%)
HDFC Bank:726.95+1.89 (+0.26%)
TCS:2,302.00+3.91 (+0.17%)
ICICI Bank:1,420.00+8.05 (+0.57%)
Power Grid Corpn:272.40+7.60 (+2.87%)
Maruti Suzuki:13,565.00-244.43 (-1.77%)
Axis Bank:1,245.80-5.25 (-0.42%)
HCL Technologies:1,302.50-15.95 (-1.21%)
O N G C:236.40-2.10 (-0.88%)
NTPC:340.00+2.50 (+0.74%)
Coal India:405.20+2.70 (+0.67%)
Bharti Airtel:1,946.00+4.27 (+0.22%)
Tech Mahindra:1,584.00-8.12 (-0.51%)
Jio Financial:244.00-0.61 (-0.25%)
Adani Ports:1,700.00+4.07 (+0.24%)
HDFC Life Insur.:554.80+12.79 (+2.36%)
SBI Life Insuran:1,792.90+10.87 (+0.61%)
Max Healthcare:1,000.00+2.10 (+0.21%)
UltraTech Cem.:11,570.00-4.63 (-0.04%)
Bajaj Auto:11,700.00-93.17 (-0.79%)
Bajaj Finserv:2,032.50+16.53 (+0.82%)
Interglobe Aviat:5,110.00-54.75 (-1.06%)
Eternal:328.00+0.07 (+0.02%)
Asian Paints:2,640.00+14.70 (+0.56%)
Cipla:1,432.20-5.75 (-0.40%)
Eicher Motors:8,010.00-32.17 (-0.40%)
Nestle India:1,477.10+19.10 (+1.31%)
Grasim Inds:3,308.00+7.92 (+0.24%)
Hindalco Inds.:1,034.00+4.12 (+0.40%)
Hind. Unilever:2,015.00-12.98 (-0.64%)
ITC:269.40-2.25 (-0.83%)
Trent:2,924.00-46.04 (-1.55%)
Larsen & Toubro:4,093.00+11.84 (+0.29%)
M & M:3,412.20-12.67 (-0.37%)
Reliance Industries:1,316.00+2.76 (+0.21%)
Tata Consumer:1,049.00-7.29 (-0.69%)
Tata Motors PVeh:317.90-2.34 (-0.73%)
Tata Steel:183.00-0.50 (-0.27%)
Wipro:180.79-0.22 (-0.12%)
Apollo Hospitals:8,693.00-41.93 (-0.48%)
Dr Reddy's Labs:1,174.70-5.31 (-0.45%)
Titan Company:5,086.10+18.24 (+0.36%)
SBI:1,048.70+0.73 (+0.07%)
Shriram Finance:1,130.00+1.81 (+0.16%)
Bharat Electron:414.00+4.59 (+1.12%)
Kotak Mah. Bank:402.80+5.44 (+1.37%)
Infosys:1,121.00-9.04 (-0.80%)
Bajaj Finance:1,095.00+0.00 (+0.00%)
Adani Enterp.:2,997.00+2.10 (+0.07%)
Sun Pharma.Inds.:1,902.40-1.52 (-0.08%)
JSW Steel:1,293.70-5.98 (-0.46%)
HDFC Bank:726.95+1.89 (+0.26%)
TCS:2,302.00+3.91 (+0.17%)
ICICI Bank:1,420.00+8.05 (+0.57%)
Power Grid Corpn:272.40+7.60 (+2.87%)
Maruti Suzuki:13,565.00-244.43 (-1.77%)
Axis Bank:1,245.80-5.25 (-0.42%)
HCL Technologies:1,302.50-15.95 (-1.21%)
O N G C:236.40-2.10 (-0.88%)
NTPC:340.00+2.50 (+0.74%)
Coal India:405.20+2.70 (+0.67%)
Bharti Airtel:1,946.00+4.27 (+0.22%)
Tech Mahindra:1,584.00-8.12 (-0.51%)
Jio Financial:244.00-0.61 (-0.25%)
Adani Ports:1,700.00+4.07 (+0.24%)
HDFC Life Insur.:554.80+12.79 (+2.36%)
SBI Life Insuran:1,792.90+10.87 (+0.61%)
Max Healthcare:1,000.00+2.10 (+0.21%)
UltraTech Cem.:11,570.00-4.63 (-0.04%)
Bajaj Auto:11,700.00-93.17 (-0.79%)
Bajaj Finserv:2,032.50+16.53 (+0.82%)
Interglobe Aviat:5,110.00-54.75 (-1.06%)
Eternal:328.00+0.07 (+0.02%)
Arihant Plus App

Arihant Plus App

Astrazeneca Pharma India Ltd

Astrazeneca Phar | 506820

Market Closed
7,415.50
91.59 (-1.22%)
As on 23/08/26, 4:33 AM
Market Cap18,538.75 CR
Current Price₹7,415.5
High / Low₹9,849.5 / 7,371.5
PE Ratio---
Book Value₹---
Dividend Yield---
ROCE---
ROE22.82%
Face Value₹2.00
Current Vol.19,159
Average Vol.---
ISININE203A01020
PB Ratio---
Debt to Equity---
Net Profit Margin---
Operating Margin---

ASTRAZEN - Share Price Chart

+0.00 (+0.00%)6M

Stock Performance

7,5077,500
7,415.5
Previous CloseToday's Open
7,371.59,849.5
7,415.5
52W Low52W High
₹7,500Today's Open
₹7,507Previous Close
19,159Volume
₹7,371.552W Low
₹9,849.552W High

Ratios

📊

Consolidated data not available

Please try selecting a different data type

About Company

  • Astrazeneca Pharma India Limited (APIL) was incorporated on July 11, 1979
  • The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company
  • The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology
  • AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL
  • Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25
  • 75% of the Company's issued and paid up equity share capital
  • Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company
  • AstraZeneca Pharmaceuticals AB Sweden
  • AstraZeneca Pharma India Limited (the Company') is a subsidiary of AstraZeneca Pharmaceuticals AB, Sweden, which is an indirect subsidiary of AstraZeneca PLC, United Kingdom
  • The company expanded the installed capacity of Injectables during the year 2001 by 0

Ethics: Astrazeneca Pharma India Ltd is flagged for

paw image

Animal Cruelty

The company engages directly in some form of animal cruelty through its business.

worldwide image

Adequate

The company demonstrates adequate ESG practices with room for improvement.

Research Calls

Research Calls
Locked Access

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI27.48
SMA 207935.05
SMA 508119.46
SMA 1008257.14
SMA 2008533.51
SMA 107719.70
MACD_12_26_Days-178.51
EMA10Day7682.58
EMA20Day7841.88
EMA50Day8060.01
MACD_12_26_9_Days-57.31
EMA100Day8238.00
EMA200Day8370.10

Pivot Points

Volume Analysis

Delivery
Total Volume
Growth Rate
📊

No Information Available

Growth Rate information is not available at this time.

All figures in ₹ Crores

📊

No Information Available

No profit & lossdata available

Show % Change
ShareHolding
📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

📊

No Information Available

No news available for this company.
Record Date
Corporate Action
Information
Announcement Day
10 Aug 2026
AGM
AGM
18 Jul 2026
31 Jul 2026
Final Dividend (₹36)
Recommended Dividend of Rs. 36/- per equity share of face value of Rs. 2 per equity share, for the financial year 2025-26, subject to approval of the shareholders. Record Date For Payment Of Final Dividend (As Per BSE Announcement Dated on: 18/07/2026)
26 May 2026
14 Aug 2025
AGM
AGM
28 Jul 2025
18 Jul 2025
Final Dividend (₹32)
Recommended Dividend of Rs. 32/- per equity share of Rs. 2/- each, subject to the approval of shareholders at the forthcoming Annual General Meeting of the Company Please find the enclosed intimation of the Company in relation to the captioned subject for your reference. (As Per BSE Announcement Dated on: 11.07.2025)
30 May 2025
08 Aug 2024
AGM
AGM
16 Jul 2024
05 Jul 2024
Final Dividend (₹24)
We wish to inform that at the meeting of Board of Directors of the Company held on May 27, 2024, the Board has recommended dividend of Rs. 24/- per equity share of Rs. 2/- each subject to the approval of the shareholders at the forthcoming AGM of the Company. Further to our intimation dated May 27, 2024, we wish to inform that the Record Date for determining the entitlement of the shareholders for the payment of Final Dividend for the financial year is July 5, 2024. The Final Dividend, if approved by the shareholders, shall be paid/ dispatched to the shareholders on or before September 6, 2024. (As Per BSE Announcement dated on 25.06.2024)
27 May 2024
14 Aug 2023
AGM
AGM
22 Jul 2023
14 Jul 2023
Final Dividend (₹16)
The Board of Directors of the Company at its Meeting held today i.e., May 30, 2023, inter alia, recommended Dividend of Rs. 16/- per equity share for the Financial Year 2022-23
30 May 2023
08 Aug 2022
AGM
AGM
15 Jul 2022
08 Jul 2022
Final Dividend (₹8)
AstraZeneca Pharma India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2022, inter alia, has recommended Final Dividend of Rs. 8/- per equity share for the financial year 2021-22. Further to our intimation dated May 26, 2022, we wish to inform that the Record Date for determining the entitlement of the shareholders for the payment of the Final Dividend for financial year 2021-22 is July 8, 2022. The Final Dividend, if approved by the shareholders, shall be paid/dispatched to the shareholders on or before September 6, 2022. (As Per BSE Announcement Dated on 27/06/2022)
26 May 2022

Peers

LTP(₹)
Market Cap(₹ Cr.)
P/E Ratio(Ratio)
P/B Ratio(Ratio)
Cash Earnings(Ratio)
Debt to Equity(Ratio)
Net Profit Ratio(%)
7,411
0
1,901
4,56,090
36
5
29
0
19.78%
8,550
2,26,976
76
14
66
0
24.32%
4,881
1,85,639
83
22
50
1
11.09%
1,426
1,15,216
32
3
24
0
9.92%
1,120
1,11,720
23
4
17
0
9.82%
2,193
1,00,271
17
4
13
0
19.16%
1,175
98,074
30
3
18
0
12.34%
1,815
98,048
90
18
62
1
13.06%
2,372
97,963
46
6
32
0
13.57%
Showing 10 of 139 Results

Frequently Asked Questions

What is Share Price of Astrazeneca Pharma India Ltd?

The current share price of Astrazeneca Pharma India Ltd (Astrazeneca Phar) is ₹7415.50. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the 52-week high and low of Astrazeneca Pharma India Ltd?

Astrazeneca Pharma India Ltd has a 52-week high of ₹9849.50 and a 52-week low of ₹7371.50. This range shows the stock's price volatility over the past year.

What is the ROE of Astrazeneca Pharma India Ltd?

Astrazeneca Pharma India Ltd has a Return on Equity (ROE) of 22.82%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

mobile

Ready to invest smarter?
Download the app today.

GET IT ON

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

DOWNLOAD ON THE

App Store

4.2